← All trials
NCT02330146
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2015
- Primary completion
- Dec 31, 2016
- Completion date
- Jun 30, 2017
- First posted
- Jan 1, 2015
- Last posted
- Sep 28, 2017
- Enrollment
- 8
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- RepliCel Life Sciences, Inc.Lead sponsor
- Innovacell Biotechnologie AGCollaborator
- Syreon CorporationCollaborator
- University of British ColumbiaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.